ATE107310T1 - Verwendung eines ghl-cu enthaltenden stoffes zur herstellung eines arzneimittels für wunden. - Google Patents

Verwendung eines ghl-cu enthaltenden stoffes zur herstellung eines arzneimittels für wunden.

Info

Publication number: ATE107310T1
Authority: AT; Austria
Prior art keywords: ghl; wounds; medication; manufacture; substance containing
Prior art date: 1985-01-24

Application number

AT86100797T

Other languages

English (en)

Inventor

Loren Ralph Pickart

Original Assignee

Procyte Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1985-01-24

Filing date

1986-01-22

Publication date

1994-07-15

1986-01-22 Application filed by Procyte Corp filed Critical Procyte Corp

1994-07-15 Application granted granted Critical

1994-07-15 Publication of ATE107310T1 publication Critical patent/ATE107310T1/de

Links

206010052428 Wound Diseases 0.000 title 1
208000027418 Wounds and injury Diseases 0.000 title 1
229940079593 drug Drugs 0.000 title 1
239000003814 drug Substances 0.000 title 1
238000004519 manufacturing process Methods 0.000 title 1
239000000126 substance Substances 0.000 title 1
241001465754 Metazoa Species 0.000 abstract 2
150000001875 compounds Chemical class 0.000 abstract 2
239000010949 copper Substances 0.000 abstract 2
JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 abstract 1
MVORZMQFXBLMHM-QWRGUYRKSA-N Gly-His-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CN=CN1 MVORZMQFXBLMHM-QWRGUYRKSA-N 0.000 abstract 1
102000019197 Superoxide Dismutase Human genes 0.000 abstract 1
108010012715 Superoxide dismutase Proteins 0.000 abstract 1
230000000890 antigenic effect Effects 0.000 abstract 1
230000004968 inflammatory condition Effects 0.000 abstract 1
229910052760 oxygen Inorganic materials 0.000 abstract 1
239000001301 oxygen Substances 0.000 abstract 1
230000000451 tissue damage Effects 0.000 abstract 1
231100000827 tissue damage Toxicity 0.000 abstract 1
230000000472 traumatic effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Gastroenterology & Hepatology (AREA)
Epidemiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Diabetes (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Hematology (AREA)
Dermatology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Compounds Of Unknown Constitution (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

AT86100797T 1985-01-24 1986-01-22 Verwendung eines ghl-cu enthaltenden stoffes zur herstellung eines arzneimittels für wunden. ATE107310T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US06/694,430 US4760051A (en)	1985-01-24	1985-01-24	Use of GHL-Cu as a wound-healing and anti-inflammatory agent

Publications (1)

Publication Number	Publication Date
ATE107310T1 true ATE107310T1 (de)	1994-07-15

Family

ID=24788792

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT86100797T ATE107310T1 (de)	1985-01-24	1986-01-22	Verwendung eines ghl-cu enthaltenden stoffes zur herstellung eines arzneimittels für wunden.

Country Status (6)

Country	Link
US (1)	US4760051A (de)
EP (2)	EP0189182B1 (de)
JP (1)	JPH0674208B2 (de)
AT (1)	ATE107310T1 (de)
CA (1)	CA1286988C (de)
DE (1)	DE3689909T2 (de)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5110795A (en) *	1984-08-09	1992-05-05	Immunetech Pharmaceuticals	Methods and compositions for the treatment of inflammatory bowel diseases and conditions
US4937230A (en) *	1985-01-24	1990-06-26	Procyte Corporation	Method of healing wounds in horses
US4810693A (en) *	1985-02-08	1989-03-07	Procyte Corporation	Method for inducing biological coverings in wounds
US5120831A (en) *	1985-02-08	1992-06-09	Procyte Corporation	Metal-peptide compositions
US5550183A (en) *	1985-02-08	1996-08-27	Procyte Corporation	Metal-peptide compositions and methods for stimulating hair growth
US5470876A (en) *	1985-07-18	1995-11-28	Proctor; Peter H.	Topical sod for treating hair loss
DE3851203T2 (de) *	1987-05-11	1994-12-15	Procyte Corp	Gebrauch von GHL-Cu Derivaten für die Herstellung eines Medikaments zur Stimulierung des Haarwachstums.
AU633005B2 (en) *	1988-06-16	1993-01-21	Procyte Corporation	Cosmetic and skin treatment compositions
US5145838A (en) *	1989-08-30	1992-09-08	Procyte Corporation	Methods and compositions for healing ulcers
US5023237A (en) *	1989-08-30	1991-06-11	Procyte Corporation	Methods and compositions for healing ulcers
US5059588A (en) *	1989-10-13	1991-10-22	Procyte Corporation, Incorporated	Methods and compositions for healing bone using gly his lys: copper
US5118665A (en) *	1990-02-09	1992-06-02	Procyte Corporation	Anti-oxidative and anti-inflammatory metal:peptide complexes and uses thereof
US5164367A (en) *	1990-03-26	1992-11-17	Procyte Corporation	Method of using copper(ii) containing compounds to accelerate wound healing
DE4038563A1 (de) *	1990-12-04	1992-06-11	Gruenenthal Gmbh	Verwendung von superoxiddismutasen zur prophylaxe und/oder behandlung von organversagen bei risikopatienten mit polytrauma
US5252559A (en) *	1991-08-20	1993-10-12	The Procter & Gamble Company	His-Gly-Gly peptide and derivatives thereof for hair growth
US6515009B1 (en)	1991-09-27	2003-02-04	Neorx Corporation	Therapeutic inhibitor of vascular smooth muscle cells
US5811447A (en)	1993-01-28	1998-09-22	Neorx Corporation	Therapeutic inhibitor of vascular smooth muscle cells
US5382431A (en) *	1992-09-29	1995-01-17	Skin Biology, Inc.	Tissue protective and regenerative compositions
US6491938B2 (en)	1993-05-13	2002-12-10	Neorx Corporation	Therapeutic inhibitor of vascular smooth muscle cells
TW239077B (de) *	1993-06-02	1995-01-21	Procyte Corp
US5425954A (en) *	1993-09-30	1995-06-20	Curafas Incorporated	Topical amino acid - vitamin complex compositions for pharmaceutical and cosmetic use
EP0755256A4 (de) *	1994-03-28	1997-09-03	Skin Biology Inc	Stärke-metall-komplexe für haut und haar
JPH07316192A (ja) *	1994-05-27	1995-12-05	Hoechst Japan Ltd	Ｌ−リシル−グリシル−ｌ−ヒスチジンおよびこれを含有する創傷治療剤
US5538945A (en) *	1994-06-17	1996-07-23	Procyte Corporation	Stimulation of hair growth by peptide copper complexes
ATE306903T1 (de)	1995-03-24	2005-11-15	Genzyme Corp	Verminderung von adhäsionen durch gesteuerte verabreichung von aktivsauerstoffinhibitoren
US5733884A (en) *	1995-11-07	1998-03-31	Nestec Ltd.	Enteral formulation designed for optimized wound healing
US5698184A (en) *	1996-08-23	1997-12-16	Skin Biology, Inc.	Compositions and methods for skin tanning and protection
US5888522A (en) *	1996-08-23	1999-03-30	Skin Biology, Inc.	Tissue protective and regenerative compositions
US6117911A (en)	1997-04-11	2000-09-12	Neorx Corporation	Compounds and therapies for the prevention of vascular and non-vascular pathologies
CN1390231A (zh)	1999-10-01	2003-01-08	Dmi生物科学公司	金属－结合性化合物及其用途
US20030130185A1 (en) *	2000-09-29	2003-07-10	David Bar-Or	Metal-binding compounds and uses therefor
US20030158111A1 (en) *	1999-10-01	2003-08-21	David Bar-Or	Methods and products for oral care
US7632803B2 (en)	1999-10-01	2009-12-15	Dmi Life Sciences, Inc.	Metal-binding compounds and uses therefor
US7592304B2 (en)	1999-10-01	2009-09-22	Dmi Life Sciences, Inc.	Metal-binding compounds and uses therefor
US20130338098A1 (en) *	2000-09-19	2013-12-19	Dermal Therapy (Barbados) Inc.	Topical Analgesic Compositions Containing Aliphatic Polyamines and Methods of Using Same
US6613083B2 (en)	2001-05-02	2003-09-02	Eckhard Alt	Stent device and method
AU2002322720B2 (en)	2001-07-25	2008-11-13	Raptor Pharmaceutical Inc.	Compositions and methods for modulating blood-brain barrier transport
WO2003030926A1 (en) *	2001-10-05	2003-04-17	Procyte Corporation	Stable solutions of peptide copper complexes and cosmetic and pharmaceutical formulations produced therefrom
KR20050033510A (ko) *	2001-10-05	2005-04-12	프로사이트 코포레이션	피부의 색소 과다 침착의 치료방법
KR20050059003A (ko) *	2002-07-02	2005-06-17	프로사이트 코포레이션	펩티드 구리 착화합물 및 연조직 충전제를 함유하는조성물
EP1545579A1 (de) *	2002-07-31	2005-06-29	Procyte Corporation	Zusammensetzungen mit peptid-kupfer-komplexen und phytochemische verbindungen sowie damit zusammenhängende verfahren
US20040138103A1 (en) *	2002-11-07	2004-07-15	Procyte Corporation	Compositions containing peptide copper complexes and metalloproteinase inhibitors and methods related thereto
US20040142853A1 (en) *	2002-11-07	2004-07-22	Procyte Corporation	Stimulation of hair growth by compositions containing peptide copper complexes and minoxidil
US7128923B2 (en) *	2003-03-31	2006-10-31	Procyte Corporation	Preserved and stable compositions containing peptide copper complexes and method related thereto
US6927205B2 (en) *	2003-04-28	2005-08-09	Procyte Corporation	Compositions and methods for treatment of psoriasis
US6927206B2 (en) *	2003-06-06	2005-08-09	Procyte Corporation	Compositions and methods for treatment of rosacea
US8734421B2 (en)	2003-06-30	2014-05-27	Johnson & Johnson Consumer Companies, Inc.	Methods of treating pores on the skin with electricity
WO2005097061A1 (en) *	2004-04-01	2005-10-20	Procyte Corporation	Encapsulated peptide copper complexes and compositions and methods related thereto
JP2008500347A (ja) *	2004-05-24	2008-01-10	ニュー・ヨーク・ユニヴァーシティー	高血糖症による血糖の急激な増加及び／又は急激な遊離脂肪酸流動の増加の病理学的影響の治療方法又は予防方法
US20060052287A1 (en) *	2004-08-18	2006-03-09	Procyte Corporation	Polyethylene glycol - peptide copper complexes and compositions and methods related thereto
EP1643094B1 (de) *	2004-10-01	2009-06-17	J. Eberspächer GmbH & Co. KG	Abgasanlage für eine Brennkraftmaschine und zugehöriges Betriebsverfahren
US20060111778A1 (en) *	2004-10-29	2006-05-25	Michalow Alexander E	Methods of promoting healing of cartilage defects and method of causing stem cells to differentiate by the articular chondrocyte pathway
US20060216258A1 (en)	2005-03-24	2006-09-28	Singleton Laura C	Water-in-silicone emulsion compositions
CA2789262C (en)	2005-04-28	2016-10-04	Proteus Digital Health, Inc.	Pharma-informatics system
WO2006126188A2 (en) *	2005-05-25	2006-11-30	Hadasit Medical Research Services And Development Ltd.	Cxcr4 antagonists for wound healing and re-epithelialization
DE102005026069A1 (de) *	2005-06-07	2006-12-14	Goldschmidt Gmbh	Topische kosmetische Formulierungen zur Regulierung und Verbesserung des Feuchtigkeitsgehalts der Haut
KR101324578B1 (ko)	2006-02-03	2013-11-01	제이알 켐, 엘엘씨	구리 및 아연 조성물을 사용하는 노화 방지 치료법
US7687650B2 (en)	2006-02-03	2010-03-30	Jr Chem, Llc	Chemical compositions and methods of making them
US7897800B2 (en)	2006-02-03	2011-03-01	Jr Chem, Llc	Chemical compositions and methods of making them
EP2063905B1 (de)	2006-09-18	2014-07-30	Raptor Pharmaceutical Inc	Behandlungen von lebererkrankungen durch verabreichung von konjugaten aus rezeptor-assoziierten proteinen
US7867522B2 (en)	2006-09-28	2011-01-11	Jr Chem, Llc	Method of wound/burn healing using copper-zinc compositions
ES2421262T3 (es) *	2007-11-30	2013-08-30	Evonik Goldschmidt Gmbh	Composición para el cuidado personal y cosmética que contiene tetrapéptidos con las unidades CX1X2G, PX1X2P o PX1X2K
US8273791B2 (en)	2008-01-04	2012-09-25	Jr Chem, Llc	Compositions, kits and regimens for the treatment of skin, especially décolletage
US10098857B2 (en)	2008-10-10	2018-10-16	The Board Of Trustees Of The Leland Stanford Junior University	Topical and transdermal delivery of HIF-1 modulators to prevent and treat chronic wounds
CA2742285A1 (en) *	2008-10-30	2010-05-27	Ohso Clean, Inc.	Antimicrobial foamable soaps
CA2750636C (en)	2009-01-23	2017-07-25	Jr Chem, Llc	Rosacea treatments and kits for performing them
TR201908314T4 (tr)	2009-02-20	2019-06-21	2 Bbb Medicines B V	Glutatyon bazlı ilaç dağıtım sistemi.
US20120089232A1 (en)	2009-03-27	2012-04-12	Jennifer Hagyoung Kang Choi	Medical devices with galvanic particulates
KR101909711B1 (ko)	2009-05-06	2018-12-19	라보라토리 스킨 케어, 인크.	활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
EP2542209A1 (de)	2010-03-01	2013-01-09	Johnson & Johnson Consumer Companies, Inc.	Hautpflegezusammensetzung mit erwünschter farbe in loser form
US20120077778A1 (en)	2010-09-29	2012-03-29	Andrea Bourdelais	Ladder-Frame Polyether Conjugates
US8952057B2 (en)	2011-01-11	2015-02-10	Jr Chem, Llc	Compositions for anorectal use and methods for treating anorectal disorders
ITRM20130199A1 (it)	2013-04-03	2014-10-04	Irbm Science Park S P A	Peptidi per uso dermatologico e/o cosmetico
WO2019055490A1 (en)	2017-09-14	2019-03-21	The Board Of Trustees Of The Leland Stanford Junior University	PACKAGING OF IRRADIED FABRIC FOR FAT GREETING RETENTION

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3551554A (en) *	1968-08-16	1970-12-29	Crown Zellerbach Corp	Enhancing tissue penetration of physiologically active agents with dmso
US4440788A (en) *	1980-05-13	1984-04-03	Mitsubishi Chemical Industries, Limited	Cysteine derivatives
US4591648A (en) *	1981-04-01	1986-05-27	National Research Development Corp.	Histidine protection

1985
- 1985-01-24 US US06/694,430 patent/US4760051A/en not_active Expired - Lifetime
1986
- 1986-01-21 CA CA000499974A patent/CA1286988C/en not_active Expired - Lifetime
- 1986-01-22 EP EP86100797A patent/EP0189182B1/de not_active Expired - Lifetime
- 1986-01-22 DE DE3689909T patent/DE3689909T2/de not_active Expired - Lifetime
- 1986-01-22 EP EP19930112423 patent/EP0577151A1/de not_active Withdrawn
- 1986-01-22 AT AT86100797T patent/ATE107310T1/de not_active IP Right Cessation
- 1986-01-24 JP JP61013599A patent/JPH0674208B2/ja not_active Expired - Lifetime

Also Published As

Publication number	Publication date
EP0189182A3 (en)	1988-10-19
EP0577151A1 (de)	1994-01-05
JPS61204132A (ja)	1986-09-10
EP0189182B1 (de)	1994-06-15
EP0189182A2 (de)	1986-07-30
CA1286988C (en)	1991-07-30
US4760051A (en)	1988-07-26
DE3689909T2 (de)	1994-09-22
JPH0674208B2 (ja)	1994-09-21
DE3689909D1 (de)	1994-07-21

Legal Events

Date	Code	Title	Description
1995-01-15	UEP	Publication of translation of european patent specification
1998-10-15	REN	Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
ATE107310T1 (de)	1994-07-15	Verwendung eines ghl-cu enthaltenden stoffes zur herstellung eines arzneimittels für wunden.
DE69003652D1 (de)	1993-11-04	Verwendung von c-22 bis c-26-aliphatischen alkoholen zur behandlung entzuendlicher und viraler hauterkrankungen.
DE3881299D1 (de)	1993-07-01	Retinoide zur behandlung lichtgeschaedigter haut.
ATE21046T1 (de)	1986-08-15	Verfahren zur absorption von schwefeldioxid.
DE3785758D1 (de)	1993-06-09	Wundheilung und knochenregeneration.
DE58906676D1 (de)	1994-02-24	Ester des Retinols und/oder der Retinsäure enthaltende Aerosol-Inhalate.
NO880022L (no)	1988-01-05	Fremstilling av m-csf.
ATE119772T1 (de)	1995-04-15	Bilobalid zur anwendung als therapeutischer wirkstoff.
ATE75397T1 (de)	1992-05-15	Verwendung von vitamin e zur herstellung von arzneimitteln zur normalisierung der blutgerinnung bei therapie mit hochungesaettigten fettsaeuren vom omega-3-typ.
ATE63815T1 (de)	1991-06-15	Verwendung von zinn-protoporphyrin und zinnmesoporphyrin zur herstellung eines arzneimittels fuer die behandlung von psoriasis.
ATE70441T1 (de)	1992-01-15	Vitaminhaltiges mittel zur behandlung und zum schutz der schleimhaeute sowie verwendung von vitamin e zur herstellung des mittels.
SE7813182L (sv)	1979-06-24	Impregnerat aktivt kol for anvendning som luftreningsmedel och sett for dess framstellning
DE69804130D1 (de)	2002-04-11	Verwendung eines gemischs aus einem diol und einer alpha-hydroxysäure zur behandlung hyperkeratotischer hauterkrankungen
DK0414076T3 (da)	1995-02-27	Cyclisk substituerede (quinolin-2-yl-methoxy)phenyleddikesyrederivater
DK472688A (da)	1989-03-02	Anvendelse af bezafibrat til behandling af diabetes
DK137589A (da)	1989-05-19	Salicylsyreholdigt middel til behandling af hudsygdomme
PT86552A (de)	1988-02-01	Gama-glutamyl-transpeptidase deren herstellung und deren verwendung
LV12140A (lv)	1998-09-20	Metode un kompozicija bioaktivu vielu imunologiskas aktivitates noteiksanai
IT1174284B (it)	1987-07-01	Procedimento per il trattamento di rivelatori di ossigeno in gas di scarico
DE3769347D1 (de)	1991-05-23	Polyprenylalkohol enthaltende injektionspraeparate und ihre verwendung.
DE3686097D1 (de)	1992-08-27	Verwendung von dopamin-agonisten zur herstellung eines arzneimittels zur behandlung von psychostimulant-sucht.
DE68921051D1 (de)	1995-03-23	Pyridin-3-percarboxylsäure monopersulfat.
ATE70444T1 (de)	1992-01-15	Topische methotrexatzubereitung zur behandlung hyperproliferativer epithelerkrankungen.
ATE40521T1 (de)	1989-02-15	Verwendung eines substanzgemisches fuer die herstellung eines mittels gegen buergers krankheit.
DE59310242D1 (de)	2002-01-17	Verwendung von Mangan-Superoxiddismutase (Mn-SOD) zur Herstellung von Arzneimitteln zur Behandlung von Erkrankungen in niedriger Dosierung